List of All Articles with Tag 'lly us'

The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.

Altimmune Inc. jumped as much as 66% in late trading after the biotech company reported results from a

A top-performing European fund manager is calling time on “hype” around weight-loss drugs that has sent Novo Nordisk

Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this

A niche issuer is launching a biotechnology exchange-traded fund whose key holdings include firms benefiting from the hype

Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to

Novo Nordisk A/S shares surged after a key study backed the use of Wegovy, its blockbuster weight-loss drug,

A single dose of an experimental drug from Eli Lilly & Co. cut by 94% a risk factor

Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss

The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans. While

Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as

Shares in Asia fell after Jerome Powell warned interest rates may have to climb further, stunting a rally